TY  - GEN
AU  - Tang,Sydney C W
AU  - Lin,Miao
AU  - Tam,Sidney
AU  - Au,Wo Shing
AU  - Ma,Maggie K M
AU  - Yap,Desmond Y H
AU  - Ho,Yiu Wing
AU  - Lai,Kar Neng
TI  - Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study
SN  - 1460-2385
PY  - 2012///0913
KW  - Adult
KW  - Amides
KW  - adverse effects
KW  - Antihypertensive Agents
KW  - Confidence Intervals
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Fumarates
KW  - Glomerulonephritis, IGA
KW  - diagnosis
KW  - Hong Kong
KW  - Humans
KW  - Interleukin-6
KW  - analysis
KW  - Kidney Function Tests
KW  - Losartan
KW  - Male
KW  - Middle Aged
KW  - Odds Ratio
KW  - Pilot Projects
KW  - Prospective Studies
KW  - Proteinuria
KW  - prevention & control
KW  - Risk Assessment
KW  - Severity of Illness Index
KW  - Time Factors
KW  - Transforming Growth Factor beta
KW  - Treatment Outcome
KW  - Urinalysis
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/ndt/gfr349
ER  -